FDA Expands Indication for Tbo-filgrastimFDA Expands Indication for Tbo-filgrastim

The granulocyte colony-stimulating factor analog can now be self-administered by patients, with the new expanded FDA indication. FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news